Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Estimated Value: $2,000,000
Open Healthcaregrant
Nov 21, 2023
Healthcare
grant
...
AI Summary
This funding opportunity from the FDA seeks proposals for developing physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro-in vivo correlations (IVIVCs) for long-acting injectable suspensions and implants. The project is a U01 grant with an optional clinical trial component.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Development of PBPK Model for Long Acting Injectable Suspensions 1 each $500,000.00 $500,000.00 Professional Services
Development of PBPK Model for Long Acting Implants 1 each $500,000.00 $500,000.00 Professional Services
Mechanistic IVIVC Development 1 each $250,000.00 $250,000.00 Professional Services
Clinical Trial (Optional) 1 each $750,000.00 $750,000.00 Medical
Estimated Bid Value$2,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids